Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Ferroptosis and cancer prognosis, and RNA Research and Splicing.
N6-methyladenosine facilitates mitochondrial fusion of colorectal cancer cells via induction of GSH synthesis and stabilization of OPA1 mRNA
FTO mediates LINE1 m <sup>6</sup> A demethylation and chromatin regulation in mESCs and mouse development
N6-methyladenosine regulates maternal RNA maintenance in oocytes and timely RNA decay during mouse maternal-to-zygotic transition
Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos
Transfer of LncRNA CRNDE in TAM-derived exosomes is linked with cisplatin resistance in gastric cancer
Exosome-mediated transfer of lncRNA HCG18 promotes M2 macrophage polarization in gastric cancer
Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets
Methionine deficiency promoted mitophagy via lncRNA PVT1-mediated promoter demethylation of BNIP3 in gastric cancer
Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients
Constructing a new prognostic signature of gastric cancer based on multiple data sets
Establishment of a prognostic model of ten transcription factors in gastric cancer
Correction to: Nuclear m6A reader YTHDC1 regulates the scaffold function of LINE1 RNA in mouse ESCs and early embryos
Identification of subtype-specific genes signature by WGCNA for prognostic prediction in diffuse type gastric cancer
Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.
PubMed 2020cited by 11position: middle
m6A facilitates hippocampus-dependent learning and memory through YTHDF1
Integrated analysis of differentially expressed profiles and construction of a competing endogenous long non-coding RNA network in renal cell carcinoma
<i>MTHFR</i> C677T and A1298C Polymorphisms Were Associated with Bladder Cancer Risk and Disease Progression: A Meta-Analysis